Abstract. The nuclear factor-κB (NF-κB) transcription factors control many physiological processes including inflammation, immunity, and apoptosis. In our search for NF-κB inhibitors from natural resources, we identified yangonin from Piper methysticum as an inhibitor of NF-κB activation. In the present study, we demonstrate that yangonin potently inhibits NF-κB activation through suppression of the transcriptional activity of the RelA/p65 subunit of NF-κB. This compound significantly inhibited the induced expression of the NF-κB-reporter gene. However, this compound did not interfere with tumor necrosis factor-α (TNF-α)-induced inhibitor of κBα (IκBα) degradation, p65 nuclear translocation, and DNA-binding activity of NF-κB. Further analysis revealed that yangonin inhibited not only the induced NF-κB activation by overexpression of RelA/p65, but also transactivation activity of RelA/p65. Moreover, yangonin did not inhibit TNF-α-induced activation of p38, but it significantly impaired activation of extracellular signal-regulated kinase 1/2 and stress-activated protein kinase/c-Jun NH 2 -terminal kinase. We also demonstrated that pretreatment of cells with this compound prevented TNF-α-induced expression of NF-κB target genes, such as interleukin 6, interleukin 8, monocyte chemotactic protein 1, cyclooxygenase-2 and inducible nitric oxide. Taken together, yangonin could be a valuable candidate for the intervention of NF-κB-dependent pathological conditions such as inflammation.
Introduction
Nuclear factor-κB (NF-κB) represents a family of eukaryotic transcription factors participating in the regulation of various cellular genes involved in the immediate early processes of immune, acute phase, and inflammatory responses as well as genes involved in cell survival (1) . NF-κB consists of a family of transcription factors including p65 (RelA), p105/p50, p100/p52, RelB, and c-Rel. The classic form of NF-κB is the p65/p50 heterodimer that contains the transcriptional activation domain and is sequestered in the cytoplasm as an inactive complex by inhibitor of κB (IκB) (2) . In response to stimulation, such as lipopolysaccharide (LPS) or tumor necrosis factor-α (TNF-α), IκBs are rapidly ubiquitinated and degraded by 26S proteasome complex and the release of IκB unmasks the nuclear localization signal and results in the translocation of NF-κB to the nucleus, followed by the activation of specific target genes (3) . Furthermore, NF-κB activation can be positively regulated by p65 post-translational modification, in which phosphorylation at various amino acid residues in p65 were found to contribute to its transcriptional activities by affecting the transcription regulators recruitment (4) .
It is reported that NF-κB regulates more than 150 genes, including those involved in immunity and inflammation, anti-apoptosis, cell proliferation, tumorigenesis, and the negative feedback of the NF-κB signal (5) . NF-κB regulates major inflammatory cytokines, including interleukin 6 (IL-6), interleukin 8 (IL-8), and monocyte chemotactic protein 1 (MCP1), many of which are potent activators for NF-κB (6) . Therefore, NF-κB is primarily an inducer of inflammatory cytokines. Its inhibitors could be useful as anti-inflammatory agents. In addition to regulating the expression of genes important for immune and inflammatory responses, NF-κB also controls the transcription of genes that are critical in the early and late stages of aggressive cancers, including cyclooxygenase-2 (COX-2) and inducible nitric oxide (iNOS). Therefore, the NF-κB function inhibitors might also be useful as anticancer agents.
Yangonin is one of the six major kavalactones found in Piper methysticum. This compound was shown to have not only potent antioxidant or free radical-scavenging activities, but also the ability to inhibit cyclooxygenase enzyme cyclooxygenase-1 (COX-1) and COX-2 (7). Yangonin also inhibited LPS-and TNF-α-induced NF-κB activation (8, 9) ; however, the molecular mechanism has not been sufficiently explained. In present study, we investigated the effects of yangonin on the NF-κB activation pathway induced by TNF-α. The results described below showed that yangonin inhibited not only NF-κB by the suppression of transactivation activity of RelA/ p65 subunit without affecting the induced degradation of IκBα, p65 nuclear translocation, and DNA-binding activity of NF-κB, but also the induced expression of NF-κB target genes such as IL-6, IL-8, MCP1, COX-2, and iNOS.
Materials and Methods

Cell culture and reagents
RAW264.7 murine macrophages (American Type Culture Collection, Manassas, VA, USA) and HeLa human cervix carcinoma (American Type Culture Collection) cells were grown in DMEM (Invitrogen, Carlsbad, CA, USA) with penicillin (100 units/ml) -streptomycin (100 units/ml) (Invitrogen) and 10% heat-inactivated fetal bovine serum (Hyclone, Logan, UT, USA). TNF-α was obtained from R&D Systems (Minneapolis, MN, USA). Yangonin was obtained from the compound bank of Korea Research Institute of Bioscience and Biotechnology (Ochang, Republic of Korea). The purity of yangonin reached 99% in high-performance liquid chromatography analysis.
Measurement of cell viability by MTT assay
HeLa cells were seeded at 1 × 10 5 cells/ml in 96-well plates containing 100 μl of DMEM medium with 10% FBS and incubated overnight. Yangonin was dissolved in DMSO and DMSO was added to all plates to compensate the same volume of DMSO. After 24 h, the cells were pretreated with different concentrations of yangonin (0.1 -3 μM) for 1 h, followed by stimulation with or without TNF-α for 24 h. Subsequently, cells were cultured with MTT solution (5 mg/ml) [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] (Sigma) for 3 h. The viable cells converted MTT to formazan, which generated a blue-purple color after dissolving in 150 μl of DMSO. The absorbance at 570 nm was measured by an ELISA plate reader.
Plasmids, transfection, and luciferase reporter assay
The pNF-κB-Luc plasmid for the NF-κB luciferase reporter assay was obtained from Stratagene (La Jolla, CA, USA). A vector encoding a fusion protein between the DNA binding domain of Gal4 and activation domains of RelA/p65, Gal4-RelA , was constructed by inserting cDNA for Gal4-RelA 268-551 into pFA-CMV ( Stratagene). The 5 × Gal4-luciferase reporter gene was obtained from Stratagene. Flag-Akt was kindly provided by Dr. Jeong-Hyung Lee (Kangwon National University, Republic of Korea). Transfections were performed using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. The luciferase reporter assay was performed as described previously (10) . Briefly, HeLa cells (1 × 10 5 cells/well) were seeded in a 96-well plate for 24 h. The cells were then transfected with plasmids for each well and then incubated for a transfection period of 24 h. After that, the cell culture medium was removed and replaced with fresh medium containing various concentrations of yangonin for 30 min, followed by treatment with 20 ng/ml of TNF-α for 18 h. Luciferase activity was determined in the Microlumat plus luminometer (EG&G Berthold, Bad Wildbad, Germany) by injecting 100 μl of assay buffer containing luciferin and measuring light emission for 10 s. Co-transfection with pRL-CMV (Promega, Madison, WI, USA), which expresses Renilla luciferase, was performed to enable normalization of data for transfection efficiency.
Preparation of nuclear extracts and electrophoretic mobility shift assay (EMSA)
Electrophoretic mobility shift assay was performed as described previously (11) . HeLa cells were cultured in 6-cm dishes and allowed to adhere for 24 h and then treatment with 3 μM yangonin for 12 h following stimulation with TNF-α (20 ng/ml) for the indicated times. The cells were then harvested and washed twice with ice-cold phosphate-buffered saline (PBS), and then nuclear extracts were prepared using NE-PER reagent (Pierce, Rockford, IL, USA), according to the instructions of the manufacturer. Electrophoretic mobility shift assay was performed using a gel-shift assay system (Promega), according to the instructions of the manufacturer. A double-stranded oligonucleotide for NF-κB (Promega) was end-labeled with [γ-32 P]ATP and purified with a G-25 spin column (Boehringer Mannheim, Mannheim, Germany). Approximately 20,000 cpm of probe was used per assay. Nuclear extracts (10 μg) were incubated for 20 min at room temperature with a gel shift-binding buffer [5% glycerol, 1 mM MgCl 2 , 0.5 mM EDTA, 0.5 mM DTT, 50 mM NaCl, 10 mM Tris-HCl, pH 7.5, 50 μg/ml poly(dI-dC) poly(dI-dC)] and 32 Plabeled oligonucleotide. The DNA-protein complex formed was separated on 4% native polyacrylamide gels, and the gel was transferred to Whatman 3 MM paper, dried, and exposed to X-ray film.
Western blot analysis
HeLa cells were cultured in 10-cm dishes and allowed to adhere for 24 h. The culture medium was removed and replaced with fresh medium containing yangonin at 3 μM for 12 h and then treatment with 20 ng/ml of TNF-α for the indicated times. The cells were washed twice with ice-cold PBS and lysed in ice-cold lysis buffer (50 mM Tris-HCl, pH 7.5, 1% Nonidet P-40, 1 mM EDTA, 1 mM phenylmethyl sulfonylfluoride) supplemented with the protease inhibitor cocktail (BD Biosciences, San Diego, CA, USA). In certain experiments, the nuclear extracts were prepared using NE-PER reagent. An aliquot of protein extracts was used to determine protein concentration by the Bradford method. A 50-μg sample of wholecell extracts or 30 μg of nuclear extract protein per lane was separated by SDS-polyacrylamide gels and followed by transferring to a polyvinylidene difluoride membrane (Millipore, Bedford, MA, USA). The membrane was blocked with 5% skim milk and then incubated with the corresponding antibody. Antibodies for IκBα, p65, phospho-p65 (Ser536), phospho-Akt (Ser473), Akt, ERK, phospho-ERK, JNK, phospho-JNK, p38, and phospho-p38 were purchased from Cell Signaling Technology (Beverly, MA, USA). Antibodies for Topo-I, COX-2, and iNOS were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibody for α-tubulin was from Sigma. After binding of an appropriate secondary antibody coupled to horseradish peroxidase, proteins were visualized by enhanced chemiluminescence according to the instructions of the manufacturer (Amersham Pharmacia Biotec, Buckinghamshire, UK).
Real-time PCR
Real-time PCR was performed as previously described (2) . In brief, HeLa cells were preincubated with the indicated concentrations of yangonin at 37°C for 12 h. Following the preincubation, the HeLa cells were stimulated with TNF-α (20 ng/ml) for 1 h, harvested, and washed twice with ice-cold PBS; then total RNA was isolated from cells using RNeasy Mini kits according to the manufacturer's instructions (Qiagen, Valencia, CA, USA).
Complementary DNA was synthesized from 1 μg of total RNA in a 20-μl reverse transcription reaction mixture according to the manufacturer's protocol (Takara Bio, Kyoto). The following primer pairs were used for realtime PCR amplification: human IL-6, 5′-GAACTCCT TCTCCACAAGCGCCTT-3′ and 5′-CAAAAGACCA GTGATGATTTTCACCAGG-3′; human IL-8, 5′-TCT GCAGCTCTGTGTGAAGG-3′ and 5′-ACTTCTCCAC AACCCTCTG-3′; human MCP1, 5′-CCCCAGTCACC TGCTGTTAT-3′ and 5′-AGATCTCCTTGGCCACAA TG-3′; GAPDH, 5′-ACCAGGTGGTCTCCTCT-3′ and 5′-TGCTGTAGCCAAATTCGTTG-3′. GAPDH was used as the housekeeping gene control. The quantitative real-time PCR was carried out using power SYBR green (Bio-Rad, Hercules, CA, USA). The reactions were performed in 25-μl (total volume) mixtures containing primers at a concentration of 400 nM. The reaction conditions consisted of 10 min at 95°C and then 40 cycles of 15 s at 95°C 15 s at 58°C and 30 s at 72°C. Melting curve analysis was used to determine PCR specificity. All reactions were carried out in triplicate for each sample. The standard curve method was used to determine the amount of each transcript. Relative induction was determined by normalizing the relative expression to the untreated control samples.
Statistical analyses
All values are expressed as the mean ± S.D. A comparison of the results was performed with one-way ANOVA and Tukey's multiple comparison tests (Graphpad Software, Inc., San Diego, CA, USA). Statistically significant differences between groups were defined as P-values less than 0.05.
Results
Yangonin inhibits TNF-α-and LPS-induced NF-κB activation
In an effort to identify NF-κB inhibitors from herbal medicines, we have identified yangonin from a traditional medicinal plant, Piper methysticum (Fig. 1) . To investigate the effect of yangonin on the induced NF-κB activation by various stimuli, we performed the NF-κB-reporter assay. Yangonin dose-dependently inhibited the TNF-α-induced NF-κB-reporter gene expression ( Fig. 2A) . This compound also inhibited LPS-induced expression of NF-κB-reporter gene expression to a similar extent (Fig.  2B) . Yangonin did not display any cellular toxicity on HeLa cells up to 3 μM with or without TNF-α (20 ng/ml) ( Fig. 2: C and D) .
Yangonin inhibits TNF-α-induced NF-κB target gene expression
To investigate whether yangonin inhibits the induced expressions of NF-κB targets genes involved in early and late stages of aggressive cancers and inflammation, we analyzed TNF-α-induced expression of COX-2, iNOS, IL-6, IL-8, and MCP1. After HeLa cells were stimulated with 20 ng/ml TNF-α for different periods in the presence or absence of yangonin, the induced expression of COX-2 and iNOS were analyzed by western blotting. TNF-α significantly induced expression of COX-2 and iNOS in a time-dependent manner (Fig. 3A , left five lanes), whereas yangonin markedly suppressed TNF-α-induced expression of all these proteins (Fig. 3A, right  four lanes) . Because NF-κB regulates major inflammatory cytokines and chemokines, including IL-6, IL-8, and MCP1, many of which are potent activators for NF-κB (1, 6, 13), we examined whether yangonin can modulate the expression of these gene products induced by TNF-α. TNF-α significantly induced expression of IL-6, IL-8, and MCP1 mRNA levels, but the induced-expression was blocked by yangonin in a dose-dependent manner (Fig. 3B ). Yangonin at 3 μM almost completely inhibited the TNF-α-induced mRNA expression of IL-6, IL-8, and MCP1. Concentrations to inhibit IL-6, IL-8, and MCP1 expression are comparable with those of NF-κB inhibition.
Yangonin does not interfere with the TNF-α-induced IκBα degradation, p65 nuclear translocation, and DNAbinding activity of NF-κB
The translocation of NF-κB to the nucleus is preceded by the phosphorylation, ubiquitination, and proteolytic degradation of IκBα (14) . To determine whether inhibi- tion of TNF-α-induced NF-κB activation by yangonin is caused by inhibition of IκBα degradation, we pretreated cells with yangonin and then exposed them to TNF-α for various time periods. Cytoplasmic extracts were analyzed for the presence of IκBα with western blot analysis. IκBα was almost completely degraded in 30 min after stimulation with TNF-α and resynthesized in 1 h (Fig. 4A , left five lanes). Preincubation with yangonin, however, could not significantly prevent TNF-α-induced degradation and resynthesis of IκBα (Fig. 4A, right four lanes) . To confirm that yangonin inhibits NF-κB activation, we measured the effect of yangonin on TNF-α-induced nuclear translocation and DNA-binding activity of NF-κB. HeLa cells stimulated with TNF-α showed strong nuclear translocation and DNA-binding activity of NF-κB. However, pretreatment of yangonin did not inhibit nuclear translocation (Fig. 4B ) and DNA-binding activity of NF-κB induced by TNF-α (Fig. 4C) .
Yangonin inhibits transactivation of RelA/p65 subunit
In order to further investigate how yangonin prevents NF-κB activation, we examined the effect of yangonin on the induced NF-κB activity by overexpression of RelA/p65 subunit, which is the critical transactivation subunit of NF-κB (15, 16) . HeLa cells were either transiently transfected with 3 × κB-Luc reporter or cotransfected with plasmids bearing genes encoding the RelA/ p65. The results showed that yangonin significantly inhibited NF-κB-dependent transcription induced by overexpression of RelA/p65 in dose-dependent manner (Fig. 5A) , suggesting that yangonin could influence the 4 . Effect of yangonin on the TNF-α-induced IκBα degradation, p65 nuclear translocation and DNA-binding activity of NF-κB. HeLa cells were incubated with 3 μM yangonin for 12 h and then incubated with 20 ng/ml TNF-α for the indicated times. Cells were harvested at the indicated time points and then cytosol extracts and nuclear extracts were prepared. Cytosol IκBα (A) and nuclear p65 (B) were detected by western blot analysis. C) HeLa cells were incubated with 3 μM yangonin for 12 h and then incubated with 20 ng/ml TNF-α for the indicated times. Cells were harvested at the indicated time points and subsequently nuclear extracts were prepared and tested for DNAbinding of activated NF-κB by EMSA as described in "Materials and Methods". transactivation activity of the RelA/p65 subunit. In order to examine this possibility, we adopted a heterologous luciferase reporter system in which gene expression from the reporter plasmid pFR-luc containing Gal4-binding sites is under the control of Gal4. A construct containing the transactivating domains of RelA, Gal4-RelA 268-551 , which we created, was transfected into HeLa cells along with a luciferase reporter containing upstream Gal4 binding sites. Yangonin blocked transcriptional activity of the transactivation domain of RelA/p65 in a dose-dependent manner (Fig. 5B) . Since the efficient transcriptional activation of NF-κB depends on the phosphorylation of its active subunit RelA/p65, particularly at serine 536 residue (14), we examined whether yangonin inhibits TNF-α-induced phosphorylation of p65 at serine 536. The results showed that TNF-α induced phosphorylation of p65 as quickly as 5 min (Fig. 5C , left five lanes), and treatment of these cells with yangonin completely inhibited the phosphorylation of p65 (Fig. 5C, right four lanes) . Taken together, these data suggested that yangonin regulates the activation of NF-κB by inhibiting transactivation activity of the RelA/p65 subunit.
Yangonin inhibits TNF-α-induced phosphorylation of Akt
Since Akt has been implicated in the regulation of p65 phosphorylation and NF-κB activation (17), we further examined the effect of yangonin on the induced NF-κB activity by overexpression of Akt. As shown in Fig. 6A , yangonin treatment resulted in the inhibition of overexpression of Akt-induced NF-κB-dependent transcription in a dose-dependent manner, suggesting that yangonin might critically influence Akt activity. To further examine this possibility, we exposed the HeLa cells to yangonin for 12 h and then treated them with TNF-α for different periods. We then prepared total extracts and analyzed them for phosphorylation of Akt by western blotting. The results showed that TNF-α induced phosphorylation of Akt in a time-dependent manner and that the earliest activation occurred within 5 min after TNF-α addition (Fig. 6B, left five lanes) . However, we did not observe phosphorylation of Akt in cells pretreated with yangonin (Fig. 6B, right four lanes) .
Yangonin inhibits TNF-α-induced phosphorylation of ERK1/2 and phosphorylation of JNK/SAPK
The mitogen-activated protein (MAP) kinases such as extracellular signal-regulated kinase 1/2 (ERK1/2), stress-activated protein kinase/c-Jun NH 2 -terminal kinase (JNK/SAPK), and p38 are known to be activated by TNF-α and are important signaling molecules involved in the activation of NF-κB (18) . Therefore, we used western blotting to determine the effect of yangonin on . After 24 h, the cells were incubated for another 12 h in the presence of the indicated concentrations of yangonin, and the luciferase activity was determined as described in "Materials and Methods". Reported data represent the mean ± S.D. of three independent experiments. **P < 0.01, ***P < 0.001, significantly different when compared with Gal4 and RelA 268-551 -cotransfected normal cells. C) HeLa cells were incubated with 3 μM yangonin for 12 h and then incubated with 20 ng/ml TNF-α for the indicated times. Cells were harvested at the indicated time points and total extracts were prepared. Phospho-p65 and p65 protein level were detected by western blot analysis. Inhibition of NF-κB by Yangonin TNF-α-induced phosphorylation of ERK1/2, JNK/SAPK, and p38 in HeLa cells (Fig. 7) . Yangonin did not suppress the TNF-α-induced activation of p38. The TNF-α-induced phosphorylation of ERK1/2 and JNK/SAPK, however, were significantly inhibited by yangonin.
Discussion
The leaves and the root of Piper methysticum have been used for herbal food and medicinal products and herbal remedies used to treat anxiety, tension, and restlessness in many Pacific Ocean islands. On the other hand, Piper methysticum is a rich source of kavalactones. Extracts containing kavalactones, like yangonin, have been used for the treatment of inflammatory disease. Despite of its various pharmacological activities, the molecular mechanism has not been sufficiently explained. In present study, we identified yangonin as an inhibitor of NF-κB activation and investigated how this compound suppressed NF-κB activation.
We found that yangonin did not inhibit the phosphorylation and degradation of IκBα and DNA-binding activity of NF-κB following TNF-α stimulation, but inhibited NF-κB activation by RelA/p65-overexpression. These observations lead us to propose the hypothesis that yangonin may modify transactivation activity of the RelA/ p65 subunit of NF-κB. In order to test this hypothesis, we investigated whether yangonin suppresses the transactivation activity of the RelA/p65 subunit using the Gal4 system. As expected, yangonin significantly suppressed the transactivation activity of the RelA/p65 subunit. It is well known that NF-κB activation, characterized by phosphorylation of specific amino acid residues in the p65 subunit, is one important prerequisite for transactivation of the target genes. We included in our analysis the assessment of phosphorylation of p65. Our results show that yangonin completely inhibited the phosphorylation of p65.
The MAP kinases are known to play an important role in the activation NF-κB (19) . Therefore, future experiments were performed to determine whether yangonin tightly regulates expression of MAP kinases to induce anti-inflammatory effects in TNF-α-stimulated HeLa. Yangonin did not significantly affect activation of p38 kinase. However, yangonin prevented the activation of ERK1/2 and JNK/SAPK. A recent study has been shown that MAP kinases, such as ERK1/2 and JNK/SAPK, were activated by Akt, and their role in regulating NF-κB activation has been well-documented (20 -23) . In this regard, suppression of ERK1/2 and JNK/SAPK activation by yangonin could result from the inhibitory effect of yangonin on Akt activation. Accumulating studies have shown that NF-κB regulates a wide variety of genes whose products are involved in inflammation, carcinogenesis, and evasion of apoptosis (5) . Constitutive activation of NF-κB may up-regulate the expression of inflammatory cytokines, chemokines, cell adhesion molecules, and inflammatory gene products such as IL-6, IL-8, MCP1, COX-2, and iNOS (1, 6, 24) . Most of these genes are shown to be up-regulated in the early and late of aggressive cancers. In the present study, we have demonstrated that pretreatment with yangonin suppressed TNF-α-induced expression IL-6, IL-8, MCP1, COX-2, and iNOS. Therefore, yangonin could serve as an interesting lead compound for the development of new, potent anti-inflammatory agents.
Taken together, we have shown that yangonin inhibits the NF-κB signal cascade by preventing transcriptional activity of RelA/p65, and the induced expression of NF-κB target genes such as IL-6, IL-8, MCP1, COX-2, and iNOS. Furthermore, this study extends our understanding of the molecular mechanisms underlying the diverse biological activities of Piper methysticum that is used in traditional medicine. Further studies remain to elucidate in detail how yangonin regulates the transactivation activity of RelA/p65.
